Market Place
Sourcing Support
Polpharma Bio And Libbs Pharma Ink Biosimilar Licensing Deal
10 Dec 2025 //
PHARMIWEB
Polpharma Bio Launches Tyruko for Biosimilar MS in U.S
17 Nov 2025 //
BUSINESSWIRE
Polpharma Bio Launches Europe`s 1St Pre-Filled Syringe
21 Oct 2025 //
PRESS RELEASE
Polpharma, MS Pharma Ink Licensing Agreements for Biosimilars
02 Sep 2025 //
BUSINESSWIRE
Polpharma Bio and Fresenius Sign Licensing Agreement fo PB016
13 Aug 2025 //
BUSINESSWIRE
ProBioGen to Provide Cell Line Development Services for Polpharma
07 May 2025 //
PRESS RELEASE
Chime Partners Polpharma Biologics to Advance Biosimilar
17 Apr 2025 //
PRESS RELEASE
Rapid Growth of Polish Biotech Sector Leads to Demand for Foreign Expertise
31 Aug 2021 //
BUSINESSWIRE
Bioeq has submitted a BLA to the FDA for the ranibizumab biosimilar
06 Aug 2021 //
BUSINESSWIRE
Polpharma & Bioeq Joint Venture Submission of Biosimilar Ranibizu
06 Aug 2021 //
BUSINESSWIRE
Article: Polpharma’s Innovative Child is ready to harvest
24 Jul 2020 //
PRESS RELEASE
First subjects in ph III study with PB006 (proposed Biosimilar to Natalizumab) have been randomized
18 Nov 2019 //
PRESS RELEASE
Novartis, Lonza deepen biosimilars push with MS, arthritis drug deals
04 Sep 2019 //
REUTERS
Novartis strikes marketing deal for Polpharma’s potential Tysabri biosimilar
03 Sep 2019 //
PHARMAPHORUM
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.